MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0026483
Syris Biotech Private Limited
Syris Biotech Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹3.36 Cr
▲ 220% YoY
Net profit · FY 2022
₹19.01 Lakh
Net margin 5.7%
EBITDA · FY 2022
₹19.22 Lakh
EBITDA margin 5.7%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Syris Biotech Private Limited
Data last updated:
Syris Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 16 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC319298. Its GSTIN is 06AAYCS8214P1ZD (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Preeti Chansaulia and Ritesh Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at House No – 266B Vp Block Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2022, the company reported a revenue of ₹3.36 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19.01 Lakh (net margin 5.7%) and EBITDA of ₹19.22 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years.
The company is associated with 1 brand: Syris Biotech.
Syris Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0026483). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909DL2017PTC319298
Registration Number 319298
Incorporation Date 16 June 2017
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0026483
Recognitions & Rankings of Syris Biotech
Contact details
Syris Biotech Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No – 266B Vp Block Pitampura, New Delhi, Delhi, India – 110034
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Syris Biotech Private Limited, buy the company report.
Comprehensive company report
Syris Biotech Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Syris Biotech operates one associated brand: Syris Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying medical diagnostic equipment and reagents in India. | syrisbiotech.com |
Business activity
The main business activity of Syris Biotech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Syris Biotech Private Limited, buy the company report.
Financials of Syris Biotech Private Limited
FY 2022 filings availableSyris Biotech Private Limited reported revenue of ₹3.36 Cr (up 220% YoY) for FY 2022.
Revenue · FY 2022
₹3.36 Cr ▲ 220%
Net profit · FY 2022
₹19.01 Lakh margin 5.7%
EBITDA · FY 2022
₹19.22 Lakh margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 220%
3 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 546%
3 years · compounded
▲ 159%
Revenue has grown at a compounded annual rate (CAGR) of 62% over three years, including 220% growth in the latest year. EBITDA rose 546% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.36 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.22 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Syris Biotech Private Limited, buy the company report.
Board of directors of Syris Biotech Private Limited
Syris Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Chansaulia Also directs: Weshape Integrated Solutions Private Limited | Director | 15 Nov 2022 | 3 Years 11 Months | Current |
| Ritesh Shrivastava Also directs: Weshape Integrated Solutions Private Limited | Director | 28 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Syris Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Technomac Medical Systems Private Limited | ₹3.4 Cr (FY 2024) | -3.0% | Delhi, India | |||
| Erigo Healthcare Private Limited | ₹3.37 Cr (FY 2025) | 33.0% | Chennai, Tamil Nadu, India | |||
| PSJ Biochem Diagnostic Private Limited | ₹3.36 Cr (FY 2025) | -18.0% | New Delhi, Delhi, India | |||
| Syris Biotech Private Limitedthis company | ₹3.36 Cr (FY 2022) | ₹19.01 Lakh | 5.7% | 220.0% | New Delhi, Delhi, India |
To see the full peer comparison of Syris Biotech Private Limited, buy the company report.
Auditor
Syris Biotech Private Limited is audited by CHATURVEDI BRIJESH & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHATURVEDI BRIJESH & CO | FY 2022 | 028207N |
Shareholding
The shareholding of Syris Biotech Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Syris Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Syris Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Syris Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Syris Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAYCS8214P1ZD | Haryana | Active | 08 Aug 2017 |
To see the full GST registrations and return filing status of Syris Biotech Private Limited, buy the company report.
Recent activity
Syris Biotech Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Sharma Sonu Ashok ceased to be Director on 29 Jul 2024.
Ceased
Sharma Sonu Ashok ceased to be Director.
Ceased
Sharma Sushilkumar Ishwar Dayal ceased to be Director.
Appointed
Ritesh Shrivastava was appointed as Director.
Appointed
Preeti Chansaulia was appointed as Director.
AGM
Syris Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Syris Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
Incorporation
16 Jun 2017
Syris Biotech Private Limited was registered on 16 Jun 2017 with Roc Delhi & aged 9 years 4 months as per MCA records.
Frequently asked questions
Syris Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 16 June 2017 (9+ years old) and is registered under CIN U51909DL2017PTC319298.
Syris Biotech has 2 current directors:
- Preeti Chansaulia - Director
- Ritesh Shrivastava - Director
The latest financial statements of Syris Biotech on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Syris Biotech is 06AAYCS8214P1ZD, registered in Haryana.
The CIN (Corporate Identification Number) of Syris Biotech is U51909DL2017PTC319298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Syris Biotech was incorporated on 16 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Syris Biotech by revenue are Technomac Medical Systems Private Limited, Erigo Healthcare Private Limited, PSJ Biochem Diagnostic Private Limited, all in the Healthcare industry (Medical and Laboratory Equipment), with the same principal business activity (wholesale trading).
Sharma Sonu Ashok ceased to be Director on 29 Jul 2024. Sharma Sushilkumar Ishwar Dayal ceased to be Director on 29 Jul 2024. Ritesh Shrivastava was appointed as Director on 28 Jul 2024. Syris Biotech has 4 board changes on record in total.
Yes, Syris Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0026483).
The registered office of Syris Biotech is at House No – 266B Vp Block Pitampura, New Delhi, Delhi, India – 110034.
Syris Biotech operates in the healthcare industry, in the medical and laboratory equipment segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages